Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI

Bioxcel Therapeutics (BTAI) Technical Analysis

1,277 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Bioxcel Therapeutics Inc’s (BTAI) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Bioxcel Therapeutics Inc is a Sell.
Bioxcel Therapeutics Inc’s (BTAI) 20-Day exponential moving average is 1.24, while Bioxcel Therapeutics Inc’s (BTAI) share price is $1.19, making it a Sell.
Bioxcel Therapeutics Inc’s (BTAI) 50-Day exponential moving average is 1.52, while Bioxcel Therapeutics Inc’s (BTAI) share price is $1.19, making it a Sell.

Bioxcel Therapeutics (BTAI) Pivot Points

Jul 24, 2024, 02:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.07
1.11
1.15
1.19
1.23
1.27
1.31
Fibonacci
1.11
1.14
1.16
1.19
1.22
1.24
1.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bioxcel Therapeutics (BTAI) Moving Averages

Jul 24, 2024, 02:57 PM
Period
Simple
Exponential
MA5
1.22Sell
1.21Sell
MA10
1.21Sell
1.21Sell
MA20
1.19Buy
1.24Sell
MA50
1.49Sell
1.52Sell
MA100
2.12Sell
1.98Sell
MA200
2.72Sell
2.70Sell
Bioxcel Therapeutics Inc’s (BTAI) 10-Day exponential moving average is 1.21, while Bioxcel Therapeutics Inc’s (BTAI) share price is $1.19, making it a Sell.
Bioxcel Therapeutics Inc’s (BTAI) 100-Day exponential moving average is 1.98, while Bioxcel Therapeutics Inc’s (BTAI) share price is $1.19, making it a Sell.
Bioxcel Therapeutics Inc’s (BTAI) stock price is $1.19 and Bioxcel Therapeutics Inc’s (BTAI) 50-day simple moving average is 1.49, creating a Sell signal.
Bioxcel Therapeutics Inc’s (BTAI) stock price is $1.19 and Bioxcel Therapeutics Inc’s (BTAI) 100-day simple moving average is 2.12, creating a Sell signal.
Bioxcel Therapeutics Inc’s (BTAI) stock price is $1.19 and Bioxcel Therapeutics Inc’s (BTAI) 200-day simple moving average is 2.72, creating a Sell signal.

Bioxcel Therapeutics (BTAI) Technical Indicators

Jul 24, 2024, 02:57 PM
Name
Value
Implied Action
RSI (14)
42.00
Neutral
STOCH (9,6)
34.78
Neutral
STOCHRSI (14)
45.27
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
20.48
Neutral
Williams %R
-53.73
Buy
CCI (14)
-2.61
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
48.23
Neutral
ROC
6.25
Buy
Bioxcel Therapeutics Inc’s (BTAI) Relative Strength Index (RSI) is 42.00, creating a Neutral signal.
Bioxcel Therapeutics Inc’s (BTAI) Trend Strength Indicator (ADX) is 20.48, creating a Neutral signal.
Bioxcel Therapeutics Inc’s (BTAI) Commodity Channel Index (CCI) is -2.61, creating a Neutral signal.
Bioxcel Therapeutics Inc’s (BTAI) Price Rate of Change (ROC) is 6.25, creating a Buy signal.

FAQ

Is BTAI a Buy, Hold, or Sell?
Based on BTAI’s technical indicators, BTAI is a Sell.
    What is BTAI’s RSI (14)?
    BTAI’s RSI (14) is 42.00, which suggests BTAI is a Neutral.
      What is BTAI’s MACD?
      BTAI’s MACD is -0.07, which suggests BTAI is a Sell.
        What is BTAI’s 5-day moving average?
        BTAI’s 5-day moving average is 1.22, which suggests BTAI is a Sell.
          What is BTAI’s 20-day moving average?
          BTAI 20-day moving average is 1.19, which suggests BTAI is a Buy.
            What is BTAI’s 50-day moving average?
            BTAI’s 50-day moving average is 1.49, which suggests BTAI is a Sell.
              What is BTAI’s 200-day moving average?
              BTAI’s 200-day moving average is 2.72, which suggests BTAI is a Sell.
                What is BTAI’s Williams % R (14)?
                BTAI’s Williams % R (14) is -53.73, which suggests BTAI is a Buy.
                  What is BTAI’s CCI (14)?
                  BTAI’s CCI (14) is -2.61, which suggests BTAI is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis